| Opentrons Labworks Inc. | |
|---|---|
| Type | Private |
| Industry | |
| Founded | 2014 |
| Founder |
|
| Headquarters | , United States |
| Key people | Jon Brennan-Badal (CEO) |
| Products |
|
Number of employees | 328 (2023) |
| Website | opentrons |

Opentrons Labworks, Inc. (or Opentrons) is a biotechnology company that manufactures liquid handling robots that use open-source software, which at one point used open-source hardware but no longer does.[citation needed] Their robots can be used by scientists to manipulate small volumes of liquids for the purpose of undertaking biochemical or chemical reactions. Currently, they offer the OT-2 and Flex robots. These robots are used primarily by researchers and scientists interested in DIY biology, but they are increasingly being used by other biologists.
Current:
Discontinued:

The company originated from Genspace, a community biology laboratory in Brooklyn, New York. Will Canine, a biohacker and former Occupy Wall Street organizer, partnered with Nicholas Wagner and Chiu Chau as his eventual co-founders who he found from a DIY-bio listserve.
In 2014, the startup officially launched with financial backing from HAXLR8TR, a hardware accelerator in Shenzhen, China. In late 2014, they launch a Kickstarter campaign. They show their machine inserting DNA inside E. coli after their campaign successfully gets funded. Jonathan Brennan-Badal, who was VP of strategy at ComiXology and a board member of Genspace, joined Opentrons in 2014 and is the current CEO.
In 2016, Opentrons was part of Y Combinator's Winter cohort of startups.
Opentrons robots have had a variety of uses in the scientific and DIY community. Scientists at UCSD modified an existing OT-1 robot to automate adding in reagents and imaging their cell signaling experiments. Scientists at Carnegie Mellon University used the OT-2, Opentrons Python API, and OpenAI's GPT-4 to autonomously design, plan, and perform experiments.
During the COVID-19 pandemic, Opentrons helped set up the Pandemic Response Lab (PRL), a sequencing facility located in Queens, New York. Opentrons' robots at the PRL helped speed up turnaround time for COVID-19 testing, going from 7 to 14 days to 12 hours, and reducing costs from $2,000 to under $28. Institutions that made use of Opentrons' robots for COVID-19 testing include: Mayo Clinic, Harvard, Stanford, Caltech, MIT, and BioNTech.
As a company, Opentrons has a number of subsidiaries.